Study links abnormally high blood sugar to higher risk of death in Covid-19 patients not diagnosed with diabetes
Saturday, 11 July 2020 A new research from Wuhan, China shows that in Covid-19 patients, but without a previous diagnosis of diabetes, abnormally high blood sugar is associated with more than double the risk of death and also an increased risk of severe complications.
Neurological complications of COVID-19 can include delirium (abrupt change in the brain that causes mental confusion and emotional disruption), brain inflammation, stroke, and nerve damage, a new study has revealed. The study led by the research team at University College London (UCL) and University...
Over one million people have now died from coronavirus worldwide. This milestone comes almost nine months after the first Covid-19 death was recorded in Wuhan, China. Data captured by Johns Hopkins University shows that the USA, Brazil and India make up for nearly half the global coronavirus deaths. Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
A method for fast, cheap, yet accurate testing for COVID-19 infection has been developed by a team of researchers. The method simplifies and frees the testing from expensive reaction steps, enabling upscaling of the diagnostics. This makes the method particularly attractive for places and situations with limited resources. It is equally interesting for repeated testing and for moving resources from expensive diagnostics to other parts of the care chain. The study led by researchers at the Karolinska Institutet was published in the journal Nature Communications."We started working on the issue of developing a readily available testing method as soon as we saw the developments in Asia and southern Europe, and before the situation reached crisis point in Sweden," says principal investigator Bjorn Reinius, research leader at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet. "Our method was effectively finished already by the end of April, and we then made all the data freely available online."The spread of the new coronavirus at the end of 2019 in China's Wuhan region quickly escalated into a global pandemic. The relatively high transmission rate and a large number of asymptomatic infections led to a huge, worldwide need for fast, affordable, and effective diagnostic tests that could be performed in clinical as well as non-clinical settings.
Brazil, the second country in the world most affected by COVID-19, after the United States, registered 69,074 confirmed cases and 1,595 deaths from COVID-19 in the last 24 hours, figures that are a new..